{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:46:12Z","timestamp":1762508772414,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>\u201cSmoker's paradox\u201d is a controversial phenomenon that describes an unexpectedly favorable short-term outcome of smokers post-percutaneous coronary intervention (PCI). This study aimed to evaluate the effect of smoking status on recurrent major adverse cardiovascular events (MACEs) in patients who recently underwent PCI and to determine whether it was paradoxical.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study utilized data from the nationwide Thai PCI registry, enrolling patients during 2018\u20132019. Our study factor was smoking status, classified as current smokers, ex-smokers, and nonsmokers. The outcome of interest was the time to occurrence of a composite of MACEs (i.e., all-cause death, myocardial infarction (MI), stroke, and unplanned revascularization) evaluated at about 1-year post-PCI. A propensity score (PS) model using inverse probability weighting with regression adjustment was used to estimate the effect of smoking on the occurrence of MACE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Current smokers, ex-smokers, and non-smokers accounted for 23, 32, and 45% of the 22,741 subjects, respectively. Smokers were younger, more frequently male, and had fewer traditional atherosclerotic risk factors. Current smokers presented more frequently with ST-elevation MIs (STEMIs) and cardiogenic shock (54 and 14.6%, respectively) than non-smokers. MACE rates were 1.9, 1.2, and 1.6 per 100 patients per month in the current smokers, ex-smokers, and non-smokers, respectively. After applying a PS, patients with a history of current smoking and ex-smoking developed the onset of recurrent MACEs significantly sooner than non-smokers, with a median time of 4.4 vs. 4.9 vs. 13.5 months (<jats:italic>p<\/jats:italic> &amp;lt; 0.001), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>\u201cSmoker's paradox\u201d was not observed in our patient population. Current smokers and ex-smokers were prone to develop an earlier onset of a post-PCI MACEs than nonsmokers and need a smoke cessation program for further prevention.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.888593","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:44:32Z","timestamp":1654069472000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["No Paradoxical Effect of Smoking Status on Recurrent Cardiovascular Events in Patients Following Percutaneous Coronary Intervention: Thai PCI Registry"],"prefix":"10.3389","volume":"9","author":[{"given":"Thosaphol","family":"Limpijankit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mann","family":"Chandavimol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suphot","family":"Srimahachota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukanya","family":"Siriyotha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammarin","family":"Thakkinstian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rungroj","family":"Krittayaphong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakarin","family":"Sansanayudh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJM197902013000501","article-title":"Mortality in middle-aged smokers and non-smokers","volume":"300","author":"Friedman","year":"1979","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jama.255.8.1023","article-title":"Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry","volume":"255","author":"Vlietstra","year":"1986","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update","volume":"43","author":"Ambrose","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/eurheartj\/ehi183","article-title":"Associations between cigarette smoking, pipe\/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease","volume":"26","author":"Wannamethee","year":"2005","journal-title":"Eur Heart J."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003370","article-title":"SmokerSw WSow WSw WSM, Aronow WSw WSow WSw WSow WSAronow WSse","author":"Gupta","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0002-8703(85)90071-7","article-title":"Smoking status at the time of acute myocardial infarction and subsequent prognosis","volume":"110","author":"Kelly","year":"1985","journal-title":"Am Heart J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.amjcard.2004.05.029","article-title":"Comparison of mortality rates after acute myocardial infarction in smokers vs. non-smokers","volume":"94","author":"Jaatun","year":"2004","journal-title":"Am J Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1161\/01.CIR.87.1.53","article-title":"Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the international tissue plasminogen activator\/streptokinase mortality trial","volume":"87","author":"Barbash","year":"1993","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/hc3201.094225","article-title":"Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox?","volume":"104","author":"Cohen","year":"2001","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1056\/NEJM199703133361103","article-title":"Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization","volume":"336","author":"Hasdai","year":"1997","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.35755\/jmedassocthai.2021.10.13066","article-title":"Multi-center, prospective, nation-wide coronary angioplasty registry in Thailand (Thai PCI registry): registry design and rationale","volume":"104","author":"Sansanayudh","year":"2021","journal-title":"J Med Assoc Thail."},{"key":"B13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/sim.2580","article-title":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study","volume":"26","author":"Austin","year":"2007","journal-title":"Stat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jtcvs.2007.07.021","article-title":"Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement","volume":"134","author":"Austin","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1016\/j.ijcard.2013.06.093","article-title":"The \u201csmoker's paradox\u201d in Asian vs. non-Asian patients with percutaneous coronary intervention longer than 6 months follow-up: a collaborative meta-analysis with the ET-CHD registry","volume":"168","author":"Li","year":"2013","journal-title":"Int J Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2016060","DOI":"10.4178\/epih.e2016060","article-title":"The effect of smoking on lung cancer: ethnic differences and the smoking paradox","volume":"38","author":"Jung","year":"2016","journal-title":"Epidemiol Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1056\/NEJM199705013361802","article-title":"Coronary risk factors and plaque morphology in men with coronary disease who died suddenly","volume":"336","author":"Burke","year":"1997","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1161\/01.CIR.97.21.2110","article-title":"Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women","volume":"97","author":"Burke","year":"1998","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1001\/archinte.163.19.2301","article-title":"Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease","volume":"163","author":"Goldenberg","year":"2003","journal-title":"Arch Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3503876","article-title":"Association of baseline smoking status with long-term prognosis in patients who underwent percutaneous coronary intervention: large single-center data","author":"Liu","year":"2019","journal-title":"J Interv Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jcin.2013.11.017","article-title":"Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non\u2013ST-segment elevation acute coronary syndromes","volume":"7","author":"Robertson","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"B23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ahj.2004.01.032","article-title":"Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction\u2014The smoker's paradox revisited","volume":"150","author":"Weisz","year":"2005","journal-title":"Am Heart J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/0735-1097(95)00299-5","article-title":"Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the \u201csmoker's paradox\u201d from the GUSTO-I trial, with angiographic insights. Global utilization of Streptokinase a","volume":"26","author":"Barbash","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/01.CIR.91.2.298","article-title":"Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction","volume":"91","author":"Grines","year":"1995","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0735-1097(96)00334-8","article-title":"Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey)","volume":"28","author":"Gottlieb","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"B28","unstructured":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation11977\n            IbanezB\n            JamesS\n            AgewallS\n            AntunesMJ\n            Bucciarelli-DucciC\n            BuenoH\n          29974355Eur Heart J392018"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0251888","DOI":"10.1371\/journal.pone.0251888","article-title":"The smoking paradox in ischemic stroke patients treated with intra-arterial thrombolysis in combination with mechanical thrombectomy\u2013VISTA-Endovascular","volume":"16","author":"Kufner","year":"2021","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0008-6363(01)00520-X","article-title":"Smoking and gender","volume":"53","author":"Bolego","year":"2002","journal-title":"Cardiovasc Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2021.06.909","article-title":"Smoking and sex differences in first manifestation of cardiovascular disease","volume":"330","author":"Vasiljevic","year":"2021","journal-title":"Atherosclerosis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2165\/00003088-199936060-00004","article-title":"Drug interactions with tobacco smoking. An update","volume":"36","author":"Zevin","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1161\/CIRCULATIONAHA.109.866533","article-title":"Smoking, clopidogrel, and mortality in patients with established cardiovascular disease","volume":"120","author":"Berger","year":"2009","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.jacc.2008.12.044","article-title":"Interaction between cigarette smoking and clinical benefit of clopidogrel","volume":"53","author":"Desai","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B35","unstructured":"Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel vs. aspirin in patients at risk of Ischemic events)76977\n            FerreiroJL\n            BhattDL\n            UenoM\n            BauerD\n            AngiolilloDJ\n          24239662J Am Coll Cardiol632014"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/heartjnl-2011-301565","article-title":"Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of \u201csmokers\u201d paradox'","volume":"98","author":"Park","year":"2012","journal-title":"Heart"},{"key":"B37","doi-asserted-by":"publisher","first-page":"700","DOI":"10.20452\/pamw.14931","article-title":"Smoking and cardiovascular diseases: paradox greater than expected?","volume":"129","author":"Ramotowski","year":"2019","journal-title":"Polish Arch Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jjcc.2013.10.007","article-title":"Current cigarette smoking is an independent risk factor for subacute stent thrombosis in acute myocardial infarction patients","volume":"63","author":"Honda","year":"2014","journal-title":"J Cardiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006577","article-title":"Double-dose vs. standard-dose clopidogrel according to smoking status among patients with acute coronary syndromes undergoing percutaneous coronary intervention","author":"Bossard","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2021.06.011","article-title":"Efficacy and safety of ticagrelor vs. prasugrel in smokers and non-smokers with acute coronary syndromes","volume":"338","author":"Lahu","year":"2021","journal-title":"Int J Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"f5307","DOI":"10.1136\/bmj.f5307","article-title":"Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison","volume":"347","author":"Gagne","year":"2013","journal-title":"BMJ"},{"key":"B42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.15420\/ecr.2019.4.2","article-title":"Obesity and cardiovascular risk after quitting smoking: the latest evidence","volume":"14","author":"Hasegawa","year":"2019","journal-title":"Eur Cardiol Rev"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.888593\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:44:37Z","timestamp":1654069477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.888593\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":42,"alternative-id":["10.3389\/fcvm.2022.888593"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.888593","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"article-number":"888593"}}